BioCentury
ARTICLE | Company News

BresaGen, Hospira deal

December 18, 2006 8:00 AM UTC

HSP completed its previously announced acquisition of BGN for A$0.14 per share in cash, or about A$21 million (US$16.1 million) (see BioCentury, Aug. 21). ...